nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—peripheral nervous system neoplasm—head and neck cancer	0.707	1	CtDrD
Topotecan—ABCG2—Fluorouracil—head and neck cancer	0.0668	0.365	CbGbCtD
Topotecan—ABCG2—Docetaxel—head and neck cancer	0.051	0.279	CbGbCtD
Topotecan—ABCB1—Vinblastine—head and neck cancer	0.0223	0.122	CbGbCtD
Topotecan—ABCB1—Docetaxel—head and neck cancer	0.0184	0.101	CbGbCtD
Topotecan—CYP3A4—Vinblastine—head and neck cancer	0.0134	0.0731	CbGbCtD
Topotecan—CYP3A4—Docetaxel—head and neck cancer	0.011	0.0602	CbGbCtD
Topotecan—Metastatic neoplasm—Hydroxyurea—head and neck cancer	0.00503	0.0491	CcSEcCtD
Topotecan—Neutropenic colitis—Docetaxel—head and neck cancer	0.00434	0.0424	CcSEcCtD
Topotecan—Metastatic neoplasm—Docetaxel—head and neck cancer	0.00261	0.0255	CcSEcCtD
Topotecan—Lung neoplasm malignant—Docetaxel—head and neck cancer	0.00249	0.0244	CcSEcCtD
Topotecan—Myelosuppression—Vinblastine—head and neck cancer	0.00225	0.022	CcSEcCtD
Topotecan—Myelosuppression—Hydroxyurea—head and neck cancer	0.00205	0.0201	CcSEcCtD
Topotecan—Acute respiratory distress syndrome—Docetaxel—head and neck cancer	0.00192	0.0187	CcSEcCtD
Topotecan—Acute leukaemia—Docetaxel—head and neck cancer	0.00175	0.0171	CcSEcCtD
Topotecan—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.00174	0.017	CcSEcCtD
Topotecan—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.0016	0.0156	CcSEcCtD
Topotecan—Myelosuppression—Fluorouracil—head and neck cancer	0.00148	0.0144	CcSEcCtD
Topotecan—Bullous eruption—Docetaxel—head and neck cancer	0.00127	0.0124	CcSEcCtD
Topotecan—Extravasation—Vinblastine—head and neck cancer	0.00121	0.0118	CcSEcCtD
Topotecan—Febrile neutropenia—Fluorouracil—head and neck cancer	0.00115	0.0113	CcSEcCtD
Topotecan—Bone pain—Vinblastine—head and neck cancer	0.0011	0.0108	CcSEcCtD
Topotecan—Myelosuppression—Docetaxel—head and neck cancer	0.00107	0.0104	CcSEcCtD
Topotecan—Heartburn—Fluorouracil—head and neck cancer	0.00101	0.00984	CcSEcCtD
Topotecan—Neoplasm—Vinblastine—head and neck cancer	0.000955	0.00933	CcSEcCtD
Topotecan—Mucosal inflammation—Docetaxel—head and neck cancer	0.000904	0.00883	CcSEcCtD
Topotecan—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.000876	0.00855	CcSEcCtD
Topotecan—Neoplasm—Hydroxyurea—head and neck cancer	0.000871	0.00851	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—TNFRSF10B—head and neck cancer	0.000834	0.139	CbGpPWpGaD
Topotecan—Febrile neutropenia—Docetaxel—head and neck cancer	0.000832	0.00813	CcSEcCtD
Topotecan—Extravasation—Fluorouracil—head and neck cancer	0.000795	0.00776	CcSEcCtD
Topotecan—Intestinal obstruction—Docetaxel—head and neck cancer	0.000734	0.00717	CcSEcCtD
Topotecan—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.000732	0.00715	CcSEcCtD
Topotecan—Heartburn—Docetaxel—head and neck cancer	0.000727	0.0071	CcSEcCtD
Topotecan—Neuralgia—Docetaxel—head and neck cancer	0.000721	0.00704	CcSEcCtD
Topotecan—Interstitial lung disease—Docetaxel—head and neck cancer	0.000707	0.00691	CcSEcCtD
Topotecan—Rash erythematous—Docetaxel—head and neck cancer	0.000654	0.00639	CcSEcCtD
Topotecan—Pleural effusion—Docetaxel—head and neck cancer	0.000654	0.00639	CcSEcCtD
Topotecan—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00063	0.00616	CcSEcCtD
Topotecan—Pancytopenia—Vinblastine—head and neck cancer	0.00063	0.00615	CcSEcCtD
Topotecan—Rigors—Docetaxel—head and neck cancer	0.000613	0.00599	CcSEcCtD
Topotecan—Sepsis—Fluorouracil—head and neck cancer	0.000602	0.00588	CcSEcCtD
Topotecan—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000579	0.00566	CcSEcCtD
Topotecan—Pancytopenia—Hydroxyurea—head and neck cancer	0.000574	0.00561	CcSEcCtD
Topotecan—Extravasation—Docetaxel—head and neck cancer	0.000574	0.0056	CcSEcCtD
Topotecan—Neutropenia—Hydroxyurea—head and neck cancer	0.000565	0.00552	CcSEcCtD
Topotecan—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000551	0.00538	CcSEcCtD
Topotecan—Weight increased—Hydroxyurea—head and neck cancer	0.00055	0.00537	CcSEcCtD
Topotecan—Infestation NOS—Hydroxyurea—head and neck cancer	0.000539	0.00526	CcSEcCtD
Topotecan—Infestation—Hydroxyurea—head and neck cancer	0.000539	0.00526	CcSEcCtD
Topotecan—Haemoglobin—Vinblastine—head and neck cancer	0.000533	0.00521	CcSEcCtD
Topotecan—Haemorrhage—Vinblastine—head and neck cancer	0.000531	0.00518	CcSEcCtD
Topotecan—Blood bilirubin increased—Docetaxel—head and neck cancer	0.000529	0.00517	CcSEcCtD
Topotecan—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000528	0.00516	CcSEcCtD
Topotecan—Hypoaesthesia—Vinblastine—head and neck cancer	0.000528	0.00516	CcSEcCtD
Topotecan—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000527	0.00515	CcSEcCtD
Topotecan—Pharyngitis—Vinblastine—head and neck cancer	0.000527	0.00514	CcSEcCtD
Topotecan—Stomatitis—Hydroxyurea—head and neck cancer	0.000525	0.00513	CcSEcCtD
Topotecan—Bone pain—Docetaxel—head and neck cancer	0.000523	0.0051	CcSEcCtD
Topotecan—Lethargy—Fluorouracil—head and neck cancer	0.000514	0.00502	CcSEcCtD
Topotecan—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00051	0.00498	CcSEcCtD
Topotecan—Respiratory failure—Docetaxel—head and neck cancer	0.00051	0.00498	CcSEcCtD
Topotecan—Pulmonary embolism—Docetaxel—head and neck cancer	0.000501	0.00489	CcSEcCtD
Topotecan—Haemoglobin—Hydroxyurea—head and neck cancer	0.000486	0.00475	CcSEcCtD
Topotecan—Haemorrhage—Hydroxyurea—head and neck cancer	0.000484	0.00473	CcSEcCtD
Topotecan—Colitis—Docetaxel—head and neck cancer	0.000481	0.00469	CcSEcCtD
Topotecan—Cardiac arrest—Fluorouracil—head and neck cancer	0.000479	0.00468	CcSEcCtD
Topotecan—Neuropathy—Docetaxel—head and neck cancer	0.00047	0.00459	CcSEcCtD
Topotecan—Alopecia—Vinblastine—head and neck cancer	0.000469	0.00458	CcSEcCtD
Topotecan—Neoplasm—Docetaxel—head and neck cancer	0.000453	0.00442	CcSEcCtD
Topotecan—Angiopathy—Hydroxyurea—head and neck cancer	0.000439	0.00429	CcSEcCtD
Topotecan—Sepsis—Docetaxel—head and neck cancer	0.000434	0.00424	CcSEcCtD
Topotecan—Chills—Hydroxyurea—head and neck cancer	0.000434	0.00424	CcSEcCtD
Topotecan—Ill-defined disorder—Vinblastine—head and neck cancer	0.000429	0.00419	CcSEcCtD
Topotecan—Alopecia—Hydroxyurea—head and neck cancer	0.000428	0.00418	CcSEcCtD
Topotecan—Anaemia—Vinblastine—head and neck cancer	0.000427	0.00417	CcSEcCtD
Topotecan—Malaise—Vinblastine—head and neck cancer	0.000417	0.00407	CcSEcCtD
Topotecan—Leukopenia—Vinblastine—head and neck cancer	0.000413	0.00404	CcSEcCtD
Topotecan—Pancytopenia—Fluorouracil—head and neck cancer	0.000413	0.00404	CcSEcCtD
Topotecan—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000391	0.00382	CcSEcCtD
Topotecan—Pneumonia—Fluorouracil—head and neck cancer	0.00039	0.00381	CcSEcCtD
Topotecan—Anaemia—Hydroxyurea—head and neck cancer	0.000389	0.0038	CcSEcCtD
Topotecan—Discomfort—Vinblastine—head and neck cancer	0.000389	0.00379	CcSEcCtD
Topotecan—Infestation NOS—Fluorouracil—head and neck cancer	0.000388	0.00379	CcSEcCtD
Topotecan—Infestation—Fluorouracil—head and neck cancer	0.000388	0.00379	CcSEcCtD
Topotecan—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00038	0.00371	CcSEcCtD
Topotecan—Dermatitis bullous—Docetaxel—head and neck cancer	0.00038	0.00371	CcSEcCtD
Topotecan—Malaise—Hydroxyurea—head and neck cancer	0.00038	0.00371	CcSEcCtD
Topotecan—Stomatitis—Fluorouracil—head and neck cancer	0.000378	0.00369	CcSEcCtD
Topotecan—Leukopenia—Hydroxyurea—head and neck cancer	0.000377	0.00368	CcSEcCtD
Topotecan—Lethargy—Docetaxel—head and neck cancer	0.000371	0.00362	CcSEcCtD
Topotecan—Thrombocytopenia—Vinblastine—head and neck cancer	0.000369	0.00361	CcSEcCtD
Topotecan—Epistaxis—Fluorouracil—head and neck cancer	0.000366	0.00357	CcSEcCtD
Topotecan—Anorexia—Vinblastine—head and neck cancer	0.000359	0.00351	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000356	0.00348	CcSEcCtD
Topotecan—Discomfort—Hydroxyurea—head and neck cancer	0.000354	0.00346	CcSEcCtD
Topotecan—Haemoglobin—Fluorouracil—head and neck cancer	0.00035	0.00342	CcSEcCtD
Topotecan—Rhinitis—Fluorouracil—head and neck cancer	0.000349	0.00341	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—BCL2L1—head and neck cancer	0.000349	0.0579	CbGpPWpGaD
Topotecan—Haemorrhage—Fluorouracil—head and neck cancer	0.000348	0.0034	CcSEcCtD
Topotecan—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000347	0.00338	CcSEcCtD
Topotecan—Pharyngitis—Fluorouracil—head and neck cancer	0.000346	0.00338	CcSEcCtD
Topotecan—Infection—Hydroxyurea—head and neck cancer	0.000342	0.00334	CcSEcCtD
Topotecan—TOP1—hair follicle—head and neck cancer	0.00034	0.184	CbGeAlD
Topotecan—Paraesthesia—Vinblastine—head and neck cancer	0.000339	0.00331	CcSEcCtD
Topotecan—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000337	0.00329	CcSEcCtD
Topotecan—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000337	0.00329	CcSEcCtD
Topotecan—Skin disorder—Hydroxyurea—head and neck cancer	0.000334	0.00326	CcSEcCtD
Topotecan—Anorexia—Hydroxyurea—head and neck cancer	0.000328	0.0032	CcSEcCtD
Topotecan—Decreased appetite—Vinblastine—head and neck cancer	0.000328	0.0032	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000327	0.0032	CcSEcCtD
Topotecan—Cramp muscle—Docetaxel—head and neck cancer	0.000327	0.0032	CcSEcCtD
Topotecan—ABCG2—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.000324	0.0539	CbGpPWpGaD
Topotecan—Constipation—Vinblastine—head and neck cancer	0.000322	0.00315	CcSEcCtD
Topotecan—Pain—Vinblastine—head and neck cancer	0.000322	0.00315	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000321	0.00313	CcSEcCtD
Topotecan—Feeling abnormal—Vinblastine—head and neck cancer	0.000311	0.00303	CcSEcCtD
Topotecan—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000308	0.00301	CcSEcCtD
Topotecan—Alopecia—Fluorouracil—head and neck cancer	0.000308	0.00301	CcSEcCtD
Topotecan—Dyspnoea—Hydroxyurea—head and neck cancer	0.000307	0.00299	CcSEcCtD
Topotecan—Dyspepsia—Hydroxyurea—head and neck cancer	0.000303	0.00296	CcSEcCtD
Topotecan—Decreased appetite—Hydroxyurea—head and neck cancer	0.000299	0.00292	CcSEcCtD
Topotecan—Pancytopenia—Docetaxel—head and neck cancer	0.000298	0.00291	CcSEcCtD
Topotecan—Abdominal pain—Vinblastine—head and neck cancer	0.000298	0.00291	CcSEcCtD
Topotecan—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000297	0.0029	CcSEcCtD
Topotecan—Fatigue—Hydroxyurea—head and neck cancer	0.000296	0.0029	CcSEcCtD
Topotecan—Constipation—Hydroxyurea—head and neck cancer	0.000294	0.00287	CcSEcCtD
Topotecan—Pain—Hydroxyurea—head and neck cancer	0.000294	0.00287	CcSEcCtD
Topotecan—Neutropenia—Docetaxel—head and neck cancer	0.000294	0.00287	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00029	0.0482	CbGpPWpGaD
Topotecan—Weight increased—Docetaxel—head and neck cancer	0.000286	0.00279	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—CASP8—head and neck cancer	0.000285	0.0473	CbGpPWpGaD
Topotecan—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000283	0.00277	CcSEcCtD
Topotecan—Pneumonia—Docetaxel—head and neck cancer	0.000282	0.00275	CcSEcCtD
Topotecan—Anaemia—Fluorouracil—head and neck cancer	0.00028	0.00274	CcSEcCtD
Topotecan—Infestation—Docetaxel—head and neck cancer	0.00028	0.00274	CcSEcCtD
Topotecan—Infestation NOS—Docetaxel—head and neck cancer	0.00028	0.00274	CcSEcCtD
Topotecan—Hypersensitivity—Vinblastine—head and neck cancer	0.000278	0.00271	CcSEcCtD
Topotecan—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000275	0.00268	CcSEcCtD
Topotecan—Stomatitis—Docetaxel—head and neck cancer	0.000273	0.00267	CcSEcCtD
Topotecan—Body temperature increased—Hydroxyurea—head and neck cancer	0.000272	0.00265	CcSEcCtD
Topotecan—Leukopenia—Fluorouracil—head and neck cancer	0.000271	0.00265	CcSEcCtD
Topotecan—Asthenia—Vinblastine—head and neck cancer	0.00027	0.00264	CcSEcCtD
Topotecan—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000265	0.00259	CcSEcCtD
Topotecan—Epistaxis—Docetaxel—head and neck cancer	0.000264	0.00258	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000264	0.0438	CbGpPWpGaD
Topotecan—Myalgia—Fluorouracil—head and neck cancer	0.000258	0.00252	CcSEcCtD
Topotecan—Chest pain—Fluorouracil—head and neck cancer	0.000258	0.00252	CcSEcCtD
Topotecan—Diarrhoea—Vinblastine—head and neck cancer	0.000258	0.00252	CcSEcCtD
Topotecan—Discomfort—Fluorouracil—head and neck cancer	0.000255	0.00249	CcSEcCtD
Topotecan—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000253	0.00247	CcSEcCtD
Topotecan—Haemoglobin—Docetaxel—head and neck cancer	0.000253	0.00247	CcSEcCtD
Topotecan—Rhinitis—Docetaxel—head and neck cancer	0.000252	0.00246	CcSEcCtD
Topotecan—Haemorrhage—Docetaxel—head and neck cancer	0.000251	0.00246	CcSEcCtD
Topotecan—Hypoaesthesia—Docetaxel—head and neck cancer	0.00025	0.00244	CcSEcCtD
Topotecan—Pharyngitis—Docetaxel—head and neck cancer	0.00025	0.00244	CcSEcCtD
Topotecan—Dizziness—Vinblastine—head and neck cancer	0.000249	0.00243	CcSEcCtD
Topotecan—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000247	0.00242	CcSEcCtD
Topotecan—Asthenia—Hydroxyurea—head and neck cancer	0.000247	0.00241	CcSEcCtD
Topotecan—Infection—Fluorouracil—head and neck cancer	0.000246	0.0024	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—BCL2—head and neck cancer	0.000245	0.0406	CbGpPWpGaD
Topotecan—Nervous system disorder—Fluorouracil—head and neck cancer	0.000243	0.00237	CcSEcCtD
Topotecan—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000242	0.00237	CcSEcCtD
Topotecan—Vomiting—Vinblastine—head and neck cancer	0.00024	0.00234	CcSEcCtD
Topotecan—Headache—Vinblastine—head and neck cancer	0.000236	0.00231	CcSEcCtD
Topotecan—Anorexia—Fluorouracil—head and neck cancer	0.000236	0.0023	CcSEcCtD
Topotecan—Diarrhoea—Hydroxyurea—head and neck cancer	0.000235	0.0023	CcSEcCtD
Topotecan—Angiopathy—Docetaxel—head and neck cancer	0.000228	0.00223	CcSEcCtD
Topotecan—Dizziness—Hydroxyurea—head and neck cancer	0.000227	0.00222	CcSEcCtD
Topotecan—Immune system disorder—Docetaxel—head and neck cancer	0.000227	0.00222	CcSEcCtD
Topotecan—Mediastinal disorder—Docetaxel—head and neck cancer	0.000227	0.00221	CcSEcCtD
Topotecan—Chills—Docetaxel—head and neck cancer	0.000226	0.0022	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000225	0.0022	CcSEcCtD
Topotecan—Nausea—Vinblastine—head and neck cancer	0.000224	0.00219	CcSEcCtD
Topotecan—Paraesthesia—Fluorouracil—head and neck cancer	0.000222	0.00217	CcSEcCtD
Topotecan—Alopecia—Docetaxel—head and neck cancer	0.000222	0.00217	CcSEcCtD
Topotecan—Dyspnoea—Fluorouracil—head and neck cancer	0.000221	0.00215	CcSEcCtD
Topotecan—Malnutrition—Docetaxel—head and neck cancer	0.000219	0.00214	CcSEcCtD
Topotecan—Vomiting—Hydroxyurea—head and neck cancer	0.000219	0.00214	CcSEcCtD
Topotecan—Dyspepsia—Fluorouracil—head and neck cancer	0.000218	0.00213	CcSEcCtD
Topotecan—Rash—Hydroxyurea—head and neck cancer	0.000217	0.00212	CcSEcCtD
Topotecan—Dermatitis—Hydroxyurea—head and neck cancer	0.000217	0.00212	CcSEcCtD
Topotecan—ABCG2—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.000215	0.0358	CbGpPWpGaD
Topotecan—Headache—Hydroxyurea—head and neck cancer	0.000215	0.0021	CcSEcCtD
Topotecan—Decreased appetite—Fluorouracil—head and neck cancer	0.000215	0.0021	CcSEcCtD
Topotecan—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000214	0.00209	CcSEcCtD
Topotecan—Back pain—Docetaxel—head and neck cancer	0.000212	0.00207	CcSEcCtD
Topotecan—Pain—Fluorouracil—head and neck cancer	0.000212	0.00207	CcSEcCtD
Topotecan—Muscle spasms—Docetaxel—head and neck cancer	0.00021	0.00206	CcSEcCtD
Topotecan—TOP1MT—thyroid gland—head and neck cancer	0.000206	0.112	CbGeAlD
Topotecan—Nausea—Hydroxyurea—head and neck cancer	0.000204	0.00199	CcSEcCtD
Topotecan—Feeling abnormal—Fluorouracil—head and neck cancer	0.000204	0.00199	CcSEcCtD
Topotecan—Anaemia—Docetaxel—head and neck cancer	0.000202	0.00198	CcSEcCtD
Topotecan—Urticaria—Fluorouracil—head and neck cancer	0.000197	0.00192	CcSEcCtD
Topotecan—Leukopenia—Docetaxel—head and neck cancer	0.000196	0.00191	CcSEcCtD
Topotecan—Body temperature increased—Fluorouracil—head and neck cancer	0.000196	0.00191	CcSEcCtD
Topotecan—Cough—Docetaxel—head and neck cancer	0.000191	0.00187	CcSEcCtD
Topotecan—Arthralgia—Docetaxel—head and neck cancer	0.000186	0.00182	CcSEcCtD
Topotecan—Chest pain—Docetaxel—head and neck cancer	0.000186	0.00182	CcSEcCtD
Topotecan—Myalgia—Docetaxel—head and neck cancer	0.000186	0.00182	CcSEcCtD
Topotecan—TOP1—parotid gland—head and neck cancer	0.000186	0.101	CbGeAlD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000185	0.00181	CcSEcCtD
Topotecan—TOP1MT—head—head and neck cancer	0.000182	0.099	CbGeAlD
Topotecan—Hypersensitivity—Fluorouracil—head and neck cancer	0.000182	0.00178	CcSEcCtD
Topotecan—Anaphylactic shock—Docetaxel—head and neck cancer	0.000179	0.00174	CcSEcCtD
Topotecan—TOP1—saliva-secreting gland—head and neck cancer	0.000178	0.0965	CbGeAlD
Topotecan—Infection—Docetaxel—head and neck cancer	0.000177	0.00173	CcSEcCtD
Topotecan—Nervous system disorder—Docetaxel—head and neck cancer	0.000175	0.00171	CcSEcCtD
Topotecan—Pruritus—Fluorouracil—head and neck cancer	0.000175	0.00171	CcSEcCtD
Topotecan—Thrombocytopenia—Docetaxel—head and neck cancer	0.000175	0.00171	CcSEcCtD
Topotecan—Skin disorder—Docetaxel—head and neck cancer	0.000173	0.00169	CcSEcCtD
Topotecan—Anorexia—Docetaxel—head and neck cancer	0.00017	0.00166	CcSEcCtD
Topotecan—Diarrhoea—Fluorouracil—head and neck cancer	0.000169	0.00165	CcSEcCtD
Topotecan—Dizziness—Fluorouracil—head and neck cancer	0.000164	0.0016	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000163	0.00159	CcSEcCtD
Topotecan—Paraesthesia—Docetaxel—head and neck cancer	0.00016	0.00157	CcSEcCtD
Topotecan—Dyspnoea—Docetaxel—head and neck cancer	0.000159	0.00156	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000158	0.0263	CbGpPWpGaD
Topotecan—Vomiting—Fluorouracil—head and neck cancer	0.000157	0.00154	CcSEcCtD
Topotecan—Dyspepsia—Docetaxel—head and neck cancer	0.000157	0.00154	CcSEcCtD
Topotecan—Rash—Fluorouracil—head and neck cancer	0.000156	0.00152	CcSEcCtD
Topotecan—Dermatitis—Fluorouracil—head and neck cancer	0.000156	0.00152	CcSEcCtD
Topotecan—Decreased appetite—Docetaxel—head and neck cancer	0.000155	0.00152	CcSEcCtD
Topotecan—Headache—Fluorouracil—head and neck cancer	0.000155	0.00151	CcSEcCtD
Topotecan—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000154	0.00151	CcSEcCtD
Topotecan—Fatigue—Docetaxel—head and neck cancer	0.000154	0.0015	CcSEcCtD
Topotecan—ABCG2—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000153	0.0255	CbGpPWpGaD
Topotecan—Constipation—Docetaxel—head and neck cancer	0.000153	0.00149	CcSEcCtD
Topotecan—Pain—Docetaxel—head and neck cancer	0.000153	0.00149	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—TYMS—head and neck cancer	0.000152	0.0253	CbGpPWpGaD
Topotecan—Feeling abnormal—Docetaxel—head and neck cancer	0.000147	0.00144	CcSEcCtD
Topotecan—Nausea—Fluorouracil—head and neck cancer	0.000147	0.00144	CcSEcCtD
Topotecan—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000146	0.00143	CcSEcCtD
Topotecan—Abdominal pain—Docetaxel—head and neck cancer	0.000141	0.00138	CcSEcCtD
Topotecan—Body temperature increased—Docetaxel—head and neck cancer	0.000141	0.00138	CcSEcCtD
Topotecan—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00014	0.0232	CbGpPWpGaD
Topotecan—TOP1—trachea—head and neck cancer	0.000137	0.0744	CbGeAlD
Topotecan—Hypersensitivity—Docetaxel—head and neck cancer	0.000132	0.00129	CcSEcCtD
Topotecan—Asthenia—Docetaxel—head and neck cancer	0.000128	0.00125	CcSEcCtD
Topotecan—TOP1MT—lymph node—head and neck cancer	0.000128	0.0693	CbGeAlD
Topotecan—Pruritus—Docetaxel—head and neck cancer	0.000126	0.00123	CcSEcCtD
Topotecan—ABCG2—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000123	0.0204	CbGpPWpGaD
Topotecan—Diarrhoea—Docetaxel—head and neck cancer	0.000122	0.00119	CcSEcCtD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000119	0.0197	CbGpPWpGaD
Topotecan—Dizziness—Docetaxel—head and neck cancer	0.000118	0.00115	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—AKT1—head and neck cancer	0.000117	0.0194	CbGpPWpGaD
Topotecan—Vomiting—Docetaxel—head and neck cancer	0.000114	0.00111	CcSEcCtD
Topotecan—Rash—Docetaxel—head and neck cancer	0.000113	0.0011	CcSEcCtD
Topotecan—Dermatitis—Docetaxel—head and neck cancer	0.000113	0.0011	CcSEcCtD
Topotecan—Headache—Docetaxel—head and neck cancer	0.000112	0.00109	CcSEcCtD
Topotecan—TOP1—thyroid gland—head and neck cancer	0.000108	0.0589	CbGeAlD
Topotecan—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000108	0.018	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000108	0.018	CbGpPWpGaD
Topotecan—Nausea—Docetaxel—head and neck cancer	0.000106	0.00104	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	9.29e-05	0.0154	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	8.83e-05	0.0147	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	7.98e-05	0.0132	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	7.7e-05	0.0128	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—PTEN—head and neck cancer	7.39e-05	0.0123	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	7.31e-05	0.0121	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	6.95e-05	0.0116	CbGpPWpGaD
Topotecan—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	6.84e-05	0.0114	CbGpPWpGaD
Topotecan—TOP1—lymph node—head and neck cancer	6.74e-05	0.0366	CbGeAlD
Topotecan—ABCG2—parotid gland—head and neck cancer	6.59e-05	0.0357	CbGeAlD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	6.58e-05	0.0109	CbGpPWpGaD
Topotecan—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	6.57e-05	0.0109	CbGpPWpGaD
Topotecan—ABCG2—saliva-secreting gland—head and neck cancer	6.31e-05	0.0342	CbGeAlD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	6.26e-05	0.0104	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	6.26e-05	0.0104	CbGpPWpGaD
Topotecan—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	6.22e-05	0.0103	CbGpPWpGaD
Topotecan—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	5.72e-05	0.0095	CbGpPWpGaD
Topotecan—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	5.5e-05	0.00914	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	5.43e-05	0.00902	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—head and neck cancer	5.26e-05	0.00874	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	5.25e-05	0.00873	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—TP53—head and neck cancer	5.04e-05	0.00838	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.44e-05	0.00737	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—TP53—head and neck cancer	4.07e-05	0.00676	CbGpPWpGaD
Topotecan—ABCG2—thyroid gland—head and neck cancer	3.85e-05	0.0209	CbGeAlD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	3.1e-05	0.00514	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	3.03e-05	0.00503	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	2.98e-05	0.00495	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	2.94e-05	0.00488	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	2.71e-05	0.00451	CbGpPWpGaD
Topotecan—ABCB1—epithelium—head and neck cancer	2.71e-05	0.0147	CbGeAlD
Topotecan—ABCG2—Metabolism—UROD—head and neck cancer	2.7e-05	0.00449	CbGpPWpGaD
Topotecan—ABCB1—trachea—head and neck cancer	2.4e-05	0.013	CbGeAlD
Topotecan—ABCG2—lymph node—head and neck cancer	2.39e-05	0.013	CbGeAlD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	2.38e-05	0.00395	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	2.34e-05	0.00389	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CASP8—head and neck cancer	2.26e-05	0.00375	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—NAT2—head and neck cancer	2.19e-05	0.00363	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	2.16e-05	0.00358	CbGpPWpGaD
Topotecan—ABCB1—lymphoid tissue—head and neck cancer	2.09e-05	0.0113	CbGeAlD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	1.98e-05	0.00328	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	1.93e-05	0.0032	CbGpPWpGaD
Topotecan—ABCB1—thyroid gland—head and neck cancer	1.9e-05	0.0103	CbGeAlD
Topotecan—ABCB1—Allograft Rejection—IL2—head and neck cancer	1.71e-05	0.00283	CbGpPWpGaD
Topotecan—ABCB1—head—head and neck cancer	1.68e-05	0.00913	CbGeAlD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	1.67e-05	0.00278	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.64e-05	0.00272	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	1.63e-05	0.00271	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—UROD—head and neck cancer	1.46e-05	0.00243	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	1.45e-05	0.00241	CbGpPWpGaD
Topotecan—ABCB1—lymph node—head and neck cancer	1.18e-05	0.0064	CbGeAlD
Topotecan—ABCG2—Metabolism—NAT2—head and neck cancer	1.12e-05	0.00186	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	1.11e-05	0.00185	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.08e-05	0.00179	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	1.07e-05	0.00177	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.06e-05	0.00177	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.02e-05	0.0017	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.01e-05	0.00168	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—DPYD—head and neck cancer	9.84e-06	0.00163	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	9.56e-06	0.00159	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—YAP1—head and neck cancer	9.33e-06	0.00155	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	9.08e-06	0.00151	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—UROD—head and neck cancer	9e-06	0.00149	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	8.21e-06	0.00136	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	7.92e-06	0.00132	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	7.15e-06	0.00119	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	6.77e-06	0.00112	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	6.44e-06	0.00107	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	6.44e-06	0.00107	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NAT2—head and neck cancer	6.07e-06	0.00101	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—TYMS—head and neck cancer	5.61e-06	0.000931	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	5.59e-06	0.000928	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTM1—head and neck cancer	5.54e-06	0.00092	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	5.4e-06	0.000898	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—DPYD—head and neck cancer	5.32e-06	0.000883	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GPX1—head and neck cancer	5.31e-06	0.000881	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP1A1—head and neck cancer	5.25e-06	0.000872	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—YAP1—head and neck cancer	5.05e-06	0.000838	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.56e-06	0.000758	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NAT2—head and neck cancer	3.74e-06	0.000621	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—DPYD—head and neck cancer	3.28e-06	0.000544	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—head and neck cancer	3.12e-06	0.000519	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—YAP1—head and neck cancer	3.11e-06	0.000516	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—TYMS—head and neck cancer	3.03e-06	0.000503	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTM1—head and neck cancer	3e-06	0.000498	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GPX1—head and neck cancer	2.87e-06	0.000476	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP1A1—head and neck cancer	2.84e-06	0.000472	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTEN—head and neck cancer	2.72e-06	0.000452	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CA—head and neck cancer	1.92e-06	0.000319	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—TYMS—head and neck cancer	1.87e-06	0.00031	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.85e-06	0.000307	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GPX1—head and neck cancer	1.77e-06	0.000294	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.75e-06	0.000291	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—head and neck cancer	1.69e-06	0.000281	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—head and neck cancer	1.57e-06	0.000261	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTEN—head and neck cancer	1.47e-06	0.000245	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.04e-06	0.000173	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.04e-06	0.000173	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTEN—head and neck cancer	9.07e-07	0.000151	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—head and neck cancer	8.49e-07	0.000141	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CA—head and neck cancer	6.4e-07	0.000106	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—head and neck cancer	5.23e-07	8.69e-05	CbGpPWpGaD
